Navigation Links
Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa
Date:12/2/2008

WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ -- Population Services International (PSI) is launching a new comprehensive project that could dramatically reduce the number of African children dying every year from malaria. The program will provide free artemisinin-based combination therapies (ACT) given by local community health workers to poor children suspected of having malaria. This quick-response approach to treatment will be monitored to determine if it reduces the number of African children dying from malaria. It is estimated that this program will avert half a million malaria cases and 11,000 child deaths in each of the four pilot areas.

The project is funded by the Canadian International Development Agency (CIDA) and led by the non-profit organization PSI in collaboration with TDR, the Special Programme for Research and Training in Tropical Diseases. TDR is supported by UNICEF, United Nations Development Program, the World Bank and the World Health Organization. Four African countries will be selected based on a range of criteria, including high malaria burden and the existence of community health networks, through which free anti-malarial medicines and associated health promotion communications will be delivered.

What makes this program groundbreaking is that the effectiveness of the home-based approach for delivering ACT, on child mortality has never before been monitored. ACT is not yet widely available, particularly for the most poor and vulnerable people. By measuring the health impact of home-based management of malaria (HMM) with ACT over the next 2-3 years, PSI and TDR believe that the results of the project will serve as a powerful catalyst for the adoption and expansion of these programs across sub-Saharan Africa.

The majority of the 1 million people who die of malaria every year are African children under the age of five. Malaria can progress quickly in children, with as little as
'/>"/>

SOURCE Population Services International
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
2. Study finds Canadas supervised injection facility cost-effective
3. Integrated Beverage Group Launches Childrens Throat Cooler(R) in Canada
4. New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada
5. NMB's Fans and Blowers to be Represented in Canada by CST-Arwin
6. Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada
7. Growth Rate of U.S. Giving for Health Care Falls More Than 50 Percent in 2007 But Rises Almost Threefold in Canada, According to Association for Healthcare Philanthropys Annual Report on Giving
8. Worlds First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada
9. Ocean Nutrition Canada Limited Secures Their Position as the Largest Omega-3 EPA/DHA Ingredient Supplier in the World
10. Colds and flu cut by one-third in study of Canadas top cold fighter in vaccinated seniors
11. MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...July 2 Pro-life forces ...preme Court ruled to uphold a state law regulating...idelines in administering RU-486 (also known as th...of women using the drug. , , The ruling came i...lanned Parenthood to a 2004 law requiring that tho...
(Date:7/2/2009)...HIA, July 2 A new analy... 100,000 women between the ages of 0 to 84 from 20... estimates issued by the Ministry of Health, with ...youngest group studied (ages 25 to 44). , , The...ses that track major breast surgeries rather than ...
(Date:7/2/2009)...p aid shuts down one set of neurons, another set w...althDay News) -- New information about brain circu...ake the sleep aid Ambien (zolpidem) walk, eat, tal...e -- and without remembering it the next morning. ...lly conscious patients into a conscious state. ,...
(Date:7/2/2009)... July 2 Tuesday night saw the laun...rt in Barcelona where U2 kicked off their new tour... , (RED)ZONES are prime location areas directly ...hout the U2 tour. The tickets for the (RED)ZONES ...ion of the ticket sales going to the Global Fund t...
Breaking Medicine News(10 mins):Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 3Health News:Odd Behaviors on Ambien Linked to Brain Circuitry 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 3
...rapy in addition to medication show an improved cl...ed with medication, according to a new study. Rese...schemic stroke due to a blockage in the middle cer...ted with tissue plasminogen activator (t-PA) withi...
... that develops very slowly with progressive sight ...chers say heavy computer use may increase the risk...ted people, according to a new study. Researchers ...in four different Japanese companies, employing ov...
...tive and well tolerated in patients with type 1 di...ntrol comparable to a conventional insulin regimen...d either inhaled insulin with bedtime Ultralente o...ulin for six months. Hypoglycemia, or the abnormal...
...0 percent of all cigarettes consumed are smoked by...udied nearly 43,000 psychiatric patients living in... between patients' mental disorders and their nico...cent of patients used any tobacco product, 25 perc...
Other Medicine News:
(Date:7/3/2009)...July 3 BioCis Pharma Ltd., a priva...uarters in Turku, Finland,announced positive res...e(TM),emulsion cream, the company,s novel topical...-controlled study, conducted in Finland, included ...is who applied the ProtoCure,emulsion cream to th...
(Date:7/1/2009)...nd, July 1 The largest s...aken has revealed several new common,single-lette...Ps) linked to,risk of the disease. The study, by ... team from deCODE genetics (Nasdaq: DCGN ), analy...control participants from fourteen countries.,It ...
(Date:6/30/2009)...PRNewswire/ -- Accumetrics, Inc. announces that it...the enrollment of its landmark clinical trial, GRA...ow(R) Assay I mpact on T hrombosis A nd S afet...rate the value of providing clinicians with action...ers to clopidogrel (Plavix(R)). The multi-center,...
(Date:6/29/2009)...eks to Assess RSV Burden in Outpatient Setting Dur...Pediatric Research , , GAITHERSBURG, Md., Jun...e its commitment to pediatric research with today,...ive study designed to assess the burden of respira...2-to-35 weeks gestational age (GA) in outpatient s...
Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 1FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 2FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 3FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 4FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 5FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 6FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 7FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 8FDA Approves AstraZenecas SEROQUEL XR 28R 29 for the Treatment of Bipolar Depression and Bipolar Mania 8199 9EntreMed to Present at BioPartnering Europe Conference 8196 1EntreMed to Present at BioPartnering Europe Conference 8196 2EntreMed to Present at BioPartnering Europe Conference 8196 3Merck Serono Named as a Top Employer by Science Magazine 8193 1Merck Serono Named as a Top Employer by Science Magazine 8193 2Tropical rainforest and mountain species may be threatened by global warming 5314 1Tropical rainforest and mountain species may be threatened by global warming 5314 2
... from ECLIPSE, Largest Safety,Program of Intraveno... 2007 /PRNewswire-FirstCall/ -- Favorable,findings...ipine),compared to current intravenous antihyperte...sion -- a potentially harmful,elevation in blood p...- were presented for the first time at a late-brea...
..., SEOUL, Korea, March 28, 2007 /PRNewswire/ -- Don...s completed a 340 patient phase,2b "at-home" clini...ur half-life) oral phosphodiesterase type 5 (PDE5)...i-center study conducted in the,U.S. was a randomi...ned to investigate the efficacy and safety of uden...
Other Medicine Technology:Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 2Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 3Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 4Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 5Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 2Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 3Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 11 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 7.5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm.
Medicine Products: